High levels of this B-cell growth factor are known to increase BCL-2 expression in lymphoma cells (Voorzanger et al., 1996), and to correlate with a worse prognosis in DLBCL patients (Lech-Maranda et al., 2004). Here, BCL2 is linked to lymphoma.